Philip A. van Damme
Fondatore presso Stichting Sanammad
Posizioni attive di Philip A. van Damme
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Stichting Sanammad | Direttore/Membro del Consiglio | 01/01/2009 | - |
| Fondatore | 01/01/2009 | - | |
| Presidente | 01/01/2009 | - | |
| Sanammad Pharmaceuticals BV | Direttore/Membro del Consiglio | 01/01/2014 | - |
| Fondatore | 01/01/2014 | - | |
| Presidente | 01/01/2014 | - |
Storia della carriera di Philip A. van Damme
Precedenti posizioni note di Philip A. van Damme
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 01/05/2014 | 06/05/2020 |
| Direttore Tecnico/Scientifico/R&S | 01/05/2014 | 06/05/2020 | |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Direttore/Membro del Consiglio | 01/01/2012 | - |
| Direttore Tecnico/Scientifico/R&S | 30/07/2013 | - |
Formazione di Philip A. van Damme
| University of Utrecht | Doctorate Degree |
Statistiche
Distribuzione geografica
| Paesi Bassi | 5 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV |
- Borsa valori
- Insiders
- Philip A. van Damme
- Esperienza
